FindTrial
Sign In

Riximyo 500 mg concentrate for solution for infusion

DRUG2 trials

Sponsors

Semmelweis University, Instytut Hematologii I Transfuzjologii

Conditions

Childhood non-mature-B Acute Lymphoblastic LeukemiaDiffuse large B-cell lymphoma) and aggressive B-cell lymphomas (HGBCLDiffuse large B-cell lymphomas (DLBCLHigh-grade B-cell lymphoma) originate from mature B-cells at various stages of terminal differentiation

Phase 2

A phase II efficacy and safety study of cell-free circulating tumor DNA-guided commencement of second-line treatment in patients with DLBCL/HGBCL relapse
Not yet recruitingCTIS2024-518275-64-00
Instytut Hematologii I TransfuzjologiiDiffuse large B-cell lymphoma) and aggressive B-cell lymphomas (HGBCL, Diffuse large B-cell lymphomas (DLBCL, High-grade B-cell lymphoma) originate from mature B-cells at various stages of terminal differentiation
Target: 340Updated: 2025-11-24

Phase 4

A Randomized Trial of the I-BFM-SG for the Management of Childhood non-mature-B Acute Lymphoblastic Leukemia
Not yet recruitingCTIS2024-513824-41-00
Semmelweis UniversityChildhood non-mature-B Acute Lymphoblastic Leukemia
Target: 775Updated: 2025-01-13